共 50 条
- [21] Clinical efficacy and safety of anti PD-1/PD-L1 antibodies as monotherapy in patients with non-small-cell lung cancerFARMACIA HOSPITALARIA, 2021, 45 (01) : 22 - 27Zayas-Soriano, MartaBonete-Sanchez, ManuelCampillo-Lopez, JuanMarcos-Ribes, BorjaHernandez-Guio, AnaTeresa Aznar-Saliente, Ma
- [22] Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case seriesCANCER, 2019, 125 (18) : 3234 - 3241Kambhampati, SwethaBauer, Kelly E.Bracci, Paige M.Keenan, Bridget P.Behr, Spencer C.Gordan, John D.Kelley, Robin K.
- [23] Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear CellsJOURNAL OF VIROLOGY, 2018, 92 (05)Cohen, Yehuda Z.Lorenzi, Julio C. C.Seaman, Michael S.Nogueira, LilianSchoofs, TillKrassnig, LisaButler, AllisonMillard, KatrinaFitzsimons, TomasDaniell, XiaojuDizon, Juan P.Shimeliovich, IrinaMontefiori, David C.Caskey, MarinaNussenzweig, Michel C.
- [24] PD-1 inhibition in malignant melanoma and lack of clinical response in chronic lymphocytic leukemia in the same patients: a case seriesCURRENT ONCOLOGY, 2020, 27 (03) : 169 - 172Landego, IHewitt, D.Hibbert, IDhaliwal, D.Pieterse, W.Grenier, D.Wong, R.Johnston, J.Banerji, V
- [25] Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports studyFRONTIERS IN IMMUNOLOGY, 2024, 15Mordoh, JoseSchwab, ErikaBravo, Alicia InesAris, MarianaBarrio, Maria Marcela
- [26] Clinical Features and Electroencephalogram Analysis of Brain Network Functional Connectivity in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody EncephalitisJOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 7881 - 7891Guo, XiaosuShi, HuiminSun, YutengXing, YuanGuo, XinShen, ZhiyuanZheng, MengyiZhang, YaxinJia, YicunLi, YeBao, JunqiangTian, Shujuan
- [27] Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysisCARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)Wu, QiWei, RuiLiao, XinyueCui, XiaonaWang, HainingHong, Tianpei
- [29] Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort studyJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)Wagner, Nikolaus B.Lenders, Max M.Kuehl, KathrinReinhardt, LydiaAndre, FionaDudda, MilenaRing, NatalieEbel, ChiaraStaeger, RamonZellweger, CarolineLang, RolandPaar, MichaelGussek, PhilippRichtig, GeorgStuermer, Suzan H.Kimeswenger, SusanneOellinger, AngelaForschner, AndreaLeiter, UlrikeWeide, BenjaminGassenmaier, MaximilianSchraag, AmadeusKlumpp, BernhardHoetzenecker, WolframBerking, CarolaRichtig, ErikaZiemer, MirjanaMangana, JohannaTerheyden, PatrickLoquai, CarmenNguyen, Van AnhGebhardt, ChristofferMeier, FriedegundDiem, StefanCozzio, AntonioFlatz, LukasRoecken, MartinGarbe, ClausEigentler, Thomas K.
- [30] Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 651 - 660Yamazaki, NaoyaTakenouchi, TatsuyaFujimoto, ManabuIhn, HironobuUchi, HiroshiInozume, TakashiKiyohara, YoshioUhara, HisashiNakagawa, KazuhikoFurukawa, HiroshiWada, HidefumiNoguchi, KazuoShimamoto, TakashiYokota, Kenji